Alligator Bioscience utvecklar CD40-terapier för svårbehandlade cancersjukdomar. Bolaget är just nu aktuellt med en företrädesemission om cirka 280 Mkr som ska ta den ledande kandidaten mitazalimab till fas III och ett partnerskap.
0:00 Introduktion
01:40 Pipeline
02:25 Mitazalimab
05:39 Mitazalimab in the context of SoC chemotherapy
07:59 OPTIMIZE-1 data
09:03 Summary and next steps
10:35 News flow
12:25 Strategic focus
13:02 Rights issue
14:30 Example - subscription of pro rata share
15:55 Q&A
Subscribe and follow BioStock on:
YouTube https://bit.ly/Biostock
LinkedIn: https://www.linkedin.com/company/biostock
Facebook: https://www.facebook.com/biostock.se
https://www.biostock.se/
#BioStock #LifeScience #AlligatorBioscience
About BioStock
BioStock is Scandinavia's leading digital news and analysis service with an exclusive focus on the Life Science sector. Our primary editorial office and tv-studio is found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies.